Synopsis of recent research by authors named "Bao-Lei Li"
- Bao-Lei Li's recent research focuses on identifying prognostic biomarkers to enhance the effectiveness of immune checkpoint inhibitors (ICIs) in advanced cancer patients undergoing anti-PD-1/PD-L1 therapy.
- The study examines the correlation between baseline circulating levels of serum cytokines and the creatinine/cystatin C ratio (CCR) with treatment outcomes, aiming to improve personalized cancer treatment strategies.
- Conducted on 65 advanced cancer patients and 10 healthy controls, the research utilizes an automated immunoassay platform to analyze levels of various cytokines to better predict patient responses to therapy.
